Skip to main content
SpringerLink
Log in

3D Printing Techniques in the Pharmaceutical Sciences – Intellectual Property Issues

  • Chapter
  • First Online:
Book cover 3D Printing of Pharmaceuticals

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 31))

Abstract

Additive manufacturing, specifically three-dimensional printing (3DP), has been in use in the manufacture of medical devices for some time, with the FDA recently issuing draft guidance for technical considerations in this regard. More recently however, attention has turned to the use of these techniques in modern medicinal manufacture, in particular, orally administrable dosage forms and drug-loaded implants. In addition to the technical challenges faced by inventors in this field, there are a number of legal issues which are likely to develop as 3D printing becomes more widespread, more specifically regarding not only the procurement and enforcement of intellectual property rights, but also potentially arising at the interface of 3D printed pharmaceuticals with competition and consumer protection laws. Intellectual property law can be complex and varies from country to country. This chapter provides an introduction to intellectual property and a discussion of the aspects and issues that are most likely to be relevant to those working in the field of 3D printing of pharmaceuticals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WO 2016/038356, claims 1–19.

    Google Scholar 

  2. WO 2016/038356, claims 20–24.

    Google Scholar 

  3. WO 2016/038356, claim 25.

    Google Scholar 

  4. WO 2016/038356, claims 26–27.

    Google Scholar 

  5. WO 2016/038356, claims 29–31.

    Google Scholar 

  6. WO 2016/038356, claim 32.

    Google Scholar 

  7. WO 2106/038356, claim 33.

    Google Scholar 

  8. Registered Designs Act 1949 (RDA 1949).

    Google Scholar 

  9. Copyright, Designs and Patents Act 1988 (CDPA 1988).

    Google Scholar 

  10. Community Design Regulation: COUNCIL REGULATION (EC) No 6/2002 of 12 December 2001 on Community designs.

    Google Scholar 

  11. http://www.wipo.int/classifications/nice/en/.

  12. Article 4, Paris Convention for the Protection of Industrial Property of March 20, 1883, as revised at Brussels on December 14, 1900, at Washington on June 2, 1911, at The Hague on November 6, 1925, at London on June 2, 1934, at Lisbon on October 31, 1958, and at Stockholm on July 14, 1967, and as amended on September 28, 1979.

    Google Scholar 

  13. Full list available here: http://www.wipo.int/pct/en/pct_contracting_states.html.

  14. Section 2(1) PA77; Article 54(1) EPC.

    Google Scholar 

  15. Section 2(2) PA77; Article 54(2) EPC.

    Google Scholar 

  16. Merrell Dow v Norton [1996] RPC 76 HL.

    Google Scholar 

  17. Section 3(1) PA1977; Article 56 EPC.

    Google Scholar 

  18. Section 4(1) PA77; Article 57 EPC.

    Google Scholar 

  19. Section 4A(1) PA77; Article 53 EPC.

    Google Scholar 

  20. Procter & Gamble vs. OHIM, Joined Cases C-468/01 P to C-472/01 P.

    Google Scholar 

  21. Henkel C-218/01.

    Google Scholar 

  22. Section 3(2) UKTMA 1994.

    Google Scholar 

  23. Section 3(6) and Section 47(4) UKTMA 1994.

    Google Scholar 

  24. Section 39–43 UK Patents Act 1977.

    Google Scholar 

  25. Section 41 UKPA 1977.

    Google Scholar 

  26. Section 9 UKTMA 1994.

    Google Scholar 

  27. Section 5 (4) UKTMA 1994.

    Google Scholar 

  28. IRC v Muller & Co’s Margarine Ltd [1901] AC 217.

    Google Scholar 

  29. Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC [2015] EWHC 2548 (Pat).

    Google Scholar 

  30. Nestec SA & Ors v Dualit Ltd & Ors [2013] EWHC 923 (Pat).

    Google Scholar 

  31. Schütz (UK) Ltd v Werit UK Ltd [2013] UKSC 16.

    Google Scholar 

  32. United Wire Ltd v Screen Repair Services (Scotland) Ltd ([2001] RPC 24).

    Google Scholar 

  33. Subject to ratification of the Unified Patent Court Agreement by the necessary parties and subject to the outcome of a pending Court challenge in Germany.

    Google Scholar 

  34. REGULATION (EU) No 1257/2012 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection.

    Google Scholar 

  35. Articles 25 to 29 of the UPC Agreement.

    Google Scholar 

  36. Section 60(6D) UK Patents Act 1977, as amended by the Legislative Reform (Patents) Order 2014.

    Google Scholar 

  37. Section 60(6F) UK Patents Act 1977, as amended by the Legislative Reform (Patents) Order 2014.

    Google Scholar 

  38. Section 60(6E) UK Patents Act 1977, as amended by the Legislative Reform (Patents) Order 2014.

    Google Scholar 

  39. COUNCIL REGULATION (EC) No 207/2009 of 26 February 2009 amended by Regulation (EU) 2015/2424 of the European Parliament and of the Council of 16 December 2015.

    Google Scholar 

  40. Section 10 UKTMA 1994.

    Google Scholar 

  41. Case C-412/05 Aventis Pharma v OHIM (26 April 2007).

    Google Scholar 

  42. Case T-95/07 Aventis Pharma v Nycomed GmbH (21 October 2008).

    Google Scholar 

  43. Flynn Pharma Ltd. Vs. DrugsRUs and Another, Court of Appeal [2017] EWCA Civ 226.

    Google Scholar 

  44. Article 7, Directive 2008/95/EC.

    Google Scholar 

  45. Joined Cases C-427/93, C-429/93 and C-436/93, Bristol-Myers-Squibb [1996] ECR I-3457, para 79.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Beck Greener, London, UK

    Catherine Jewell & James Stones

Authors
  1. Catherine Jewell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Stones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine Jewell .

Editor information

Editors and Affiliations

  1. Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, United Kingdom

    Abdul W. Basit

  2. Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, United Kingdom

    Simon Gaisford

Rights and permissions

Reprints and permissions

Copyright information

© 2018 American Association of Pharmaceutical Scientists

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jewell, C., Stones, J. (2018). 3D Printing Techniques in the Pharmaceutical Sciences – Intellectual Property Issues. In: Basit, A., Gaisford, S. (eds) 3D Printing of Pharmaceuticals. AAPS Advances in the Pharmaceutical Sciences Series, vol 31. Springer, Cham. https://doi.org/10.1007/978-3-319-90755-0_10

Download citation

Publish with us

Policies and ethics

Search

Navigation